Search

everythinglearnresearchcommunity

for

Search:↓

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Baricitinib is effective and safe for treating severe alopecia areata.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Tofacitinib may help regrow hair in alopecia areata patients.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.